These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38300833)

  • 1. The profile of HIV-1 drug resistance in Shanghai, China: a retrospective study from 2017 to 2021.
    Zhang M; Ma Y; Wang G; Wang Z; Wang Q; Li X; Lin F; Qiu J; Chen D; Shen Y; Zhang C; Lu H
    J Antimicrob Chemother; 2024 Mar; 79(3):526-530. PubMed ID: 38300833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and transmission of pretreatment drug resistance in people living with HIV-1 in Shanghai China, 2017-2021.
    Zhang M; Ma Y; Wang Z; Wang G; Wang Q; Li X; Lin F; Zhang C
    Virulence; 2024 Dec; 15(1):2373105. PubMed ID: 38934465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution characteristics of drug resistance mutations of HIV CRF01_AE, CRF07_BC and CRF08_BC from patients under ART in Ganzhou, China.
    Xie YN; Zhu FX; Zhong YT; Chen YT; Gao Q; Lai XL; Liu JJ; Huang DD; Zhang YN; Chen X
    J Antimicrob Chemother; 2021 Oct; 76(11):2975-2982. PubMed ID: 34402512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of drug resistance in HIV-1 CRF55_01B from ART-experienced patients in Guangdong, China.
    Lan Y; Xin R; Cai W; Deng X; Li L; Li F; Cai X; Tang X; Fan Q; Hu F
    J Antimicrob Chemother; 2020 Jul; 75(7):1925-1931. PubMed ID: 32300784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diversity of HIV-1 genotypes and high prevalence of pretreatment drug resistance in newly diagnosed HIV-infected patients in Shanghai, China.
    Wang Z; Zhang M; Zhang R; Liu L; Shen Y; Wang J; Lu H
    BMC Infect Dis; 2019 Apr; 19(1):313. PubMed ID: 30961560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The genotype distribution, infection stage and drug resistance mutation profile of human immunodeficiency virus-1 among the infected blood donors from five Chinese blood centers, 2014-2017.
    Liang S; Liu Z; Wang S; Liu J; Shi L; Mao W; Liu C; Wan J; Zhu L; Huang M; Liu Y; Wang J; Ness P; Shan H; Zeng P; He M
    PLoS One; 2020; 15(12):e0243650. PubMed ID: 33347449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring disparities in HIV-1 pretreatment and acquired drug resistance in China from 2003 to 2022.
    Wang Z; Jiang H; Pang X; Li J; Liang S; Huang J; Li D; Hou W; Chen N; Lan G
    J Antimicrob Chemother; 2024 Oct; 79(10):2575-2585. PubMed ID: 39045823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural polymorphisms in HIV-1 CRF01_AE strain and profile of acquired drug resistance mutations in a long-term combination treatment cohort in northeastern China.
    Sun Z; Ouyang J; Zhao B; An M; Wang L; Ding H; Han X
    BMC Infect Dis; 2020 Feb; 20(1):178. PubMed ID: 32102660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of ART effects and drug resistance in adult HIV/AIDS patients in Meigu County, Liangshan Prefecture, China.
    Yuan L; Chen K; Cai Y; Zhou Z; Yang J; Jiqu W; Zhu Q; Zhang H; Niu S; Sun H
    BMC Infect Dis; 2024 Feb; 24(1):155. PubMed ID: 38302941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The S68G polymorphism is a compensatory mutation associated with the drug resistance mutation K65R in CRF01_AE strains.
    Li S; Ouyang J; Zhao B; An M; Wang L; Ding H; Zhang M; Han X
    BMC Infect Dis; 2020 Feb; 20(1):123. PubMed ID: 32046664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Diversity and Characteristics of Drug Resistance Among Treatment-Naive People Living with HIV in Xi'an, China.
    Xia H; Jin J; Ba H; Zhang Y; Li J; Guo R; Li Y; Ma P; Zhang Y
    Drug Des Devel Ther; 2023; 17():1485-1494. PubMed ID: 37220545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 drug resistance and genetic transmission network among newly diagnosed people living with HIV/AIDS in Ningbo, China between 2018 and 2021.
    Hong H; Tang C; Liu Y; Jiang H; Fang T; Xu G
    Virol J; 2023 Oct; 20(1):233. PubMed ID: 37833806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of HIV drug resistance profiles across HIV-1 subtypes A and D for patients receiving a tenofovir-based and zidovudine-based first line regimens in Uganda.
    Ayitewala A; Kyeyune F; Ainembabazi P; Nabulime E; Kato CD; Nankya I
    AIDS Res Ther; 2020 Jan; 17(1):2. PubMed ID: 32005262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug resistance and influencing factors in HIV-1-infected individuals under antiretroviral therapy in Guangxi, China.
    Pang X; He Q; Tang K; Huang J; Fang N; Xie H; Ma J; Zhu Q; Lan G; Liang S
    J Antimicrob Chemother; 2024 May; 79(5):1142-1152. PubMed ID: 38551451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular genetic characterization analysis of a novel HIV-1 circulating recombinant form (CRF156_0755) in Guangdong, China.
    Lin Y; Lan X; Xin R; Ling X; Xiao M; Li F; Hu F; Li L; Lan Y
    Front Microbiol; 2024; 15():1387720. PubMed ID: 38765676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 Drug Resistance and Genetic Transmission Networks Among MSM Failing Antiretroviral Therapy in South China 2014-2019.
    Lan Y; Deng X; Li L; Cai W; Li J; Cai X; Li F; Hu F; Lei C; Tang X
    Infect Drug Resist; 2021; 14():2977-2989. PubMed ID: 34377002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in HIV-1 Drug Resistance Mutations from a U.S. Reference Laboratory from 2006 to 2017.
    Kagan RM; Dunn KJ; Snell GP; Nettles RE; Kaufman HW
    AIDS Res Hum Retroviruses; 2019 Aug; 35(8):698-709. PubMed ID: 31169022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of Drug Resistance and Genetic Transmission Networks Among Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Patients with Antiretroviral Therapy Failure in Guangxi, China.
    Yu D; Liang B; Yang Y; Liu J; Liang H; Zhang F; Jiang J; Huang J; Zhong S; Qin C; Jiang J; Liang H; Ye L
    AIDS Res Hum Retroviruses; 2022 Oct; 38(10):822-830. PubMed ID: 35972723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virologic status and pattern of drug resistance mutation among ART-experienced HIV-infected patients in Butuo County, China.
    Chen M; Wu M; Zeng L; Zhang Y; Huobu-Mo M; Li J; Li C; Xiao H
    J Glob Antimicrob Resist; 2023 Mar; 32():98-103. PubMed ID: 36708768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of acquired drug resistance mutations in antiretroviral- experiencing subjects from 2012 to 2017 in Hunan Province of central South China.
    Zou X; He J; Zheng J; Malmgren R; Li W; Wei X; Zhang G; Chen X
    Virol J; 2020 Mar; 17(1):38. PubMed ID: 32183889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.